8ga2

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
(New page: '''Unreleased structure''' The entry 8ga2 is ON HOLD until Paper Publication Authors: Schonbrunn, E., Bikowitz, M. Description: Bromodomain of CBP liganded with inhibitor iCBP5 [[Categ...)
Current revision (09:35, 1 March 2024) (edit) (undo)
 
(One intermediate revision not shown.)
Line 1: Line 1:
-
'''Unreleased structure'''
 
-
The entry 8ga2 is ON HOLD until Paper Publication
+
==Bromodomain of CBP liganded with inhibitor iCBP5==
-
 
+
<StructureSection load='8ga2' size='340' side='right'caption='[[8ga2]], [[Resolution|resolution]] 1.85&Aring;' scene=''>
-
Authors: Schonbrunn, E., Bikowitz, M.
+
== Structural highlights ==
-
 
+
<table><tr><td colspan='2'>[[8ga2]] is a 4 chain structure with sequence from [https://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=8GA2 OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=8GA2 FirstGlance]. <br>
-
Description: Bromodomain of CBP liganded with inhibitor iCBP5
+
</td></tr><tr id='method'><td class="sblockLbl"><b>[[Empirical_models|Method:]]</b></td><td class="sblockDat" id="methodDat">X-ray diffraction, [[Resolution|Resolution]] 1.85&#8491;</td></tr>
-
[[Category: Unreleased Structures]]
+
<tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=EDO:1,2-ETHANEDIOL'>EDO</scene>, <scene name='pdbligand=YVK:(6S)-6-{(5M)-5-(3,5-dimethyl-1,2-oxazol-4-yl)-1-[(1s,4R)-4-methoxycyclohexyl]-1H-benzimidazol-2-yl}-1-phenylpiperidin-2-one'>YVK</scene></td></tr>
-
[[Category: Bikowitz, M]]
+
<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=8ga2 FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=8ga2 OCA], [https://pdbe.org/8ga2 PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=8ga2 RCSB], [https://www.ebi.ac.uk/pdbsum/8ga2 PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=8ga2 ProSAT]</span></td></tr>
-
[[Category: Schonbrunn, E]]
+
</table>
 +
== Disease ==
 +
[https://www.uniprot.org/uniprot/CBP_HUMAN CBP_HUMAN] Note=Chromosomal aberrations involving CREBBP may be a cause of acute myeloid leukemias. Translocation t(8;16)(p11;p13) with KAT6A; translocation t(11;16)(q23;p13.3) with MLL/HRX; translocation t(10;16)(q22;p13) with KAT6B. KAT6A-CREBBP may induce leukemia by inhibiting RUNX1-mediated transcription. Defects in CREBBP are a cause of Rubinstein-Taybi syndrome type 1 (RSTS1) [MIM:[https://omim.org/entry/180849 180849]. RSTS1 is an autosomal dominant disorder characterized by craniofacial abnormalities, broad thumbs, broad big toes, mental retardation and a propensity for development of malignancies.<ref>PMID:11331617</ref> <ref>PMID:12114483</ref> <ref>PMID:12566391</ref> <ref>PMID:15706485</ref>
 +
== Function ==
 +
[https://www.uniprot.org/uniprot/CBP_HUMAN CBP_HUMAN] Acetylates histones, giving a specific tag for transcriptional activation. Also acetylates non-histone proteins, like NCOA3 and FOXO1. Binds specifically to phosphorylated CREB and enhances its transcriptional activity toward cAMP-responsive genes. Acts as a coactivator of ALX1 in the presence of EP300.<ref>PMID:9707565</ref> <ref>PMID:11154691</ref> <ref>PMID:12738767</ref> <ref>PMID:12929931</ref>
 +
== References ==
 +
<references/>
 +
__TOC__
 +
</StructureSection>
 +
[[Category: Homo sapiens]]
 +
[[Category: Large Structures]]
 +
[[Category: Bikowitz M]]
 +
[[Category: Schonbrunn E]]

Current revision

Bromodomain of CBP liganded with inhibitor iCBP5

PDB ID 8ga2

Drag the structure with the mouse to rotate

Proteopedia Page Contributors and Editors (what is this?)

OCA

Personal tools